InMed Pharmaceuticals Inc
NASDAQ:INM
InMed Pharmaceuticals Inc
NASDAQ:INM
Price:
0.7147
USD
0.29%
Market Cap:
$2.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
InMed Pharmaceuticals Inc
NASDAQ:INM
|
CA |
|
InPost SA
AEX:INPST
|
LU |
|
R
|
Radiant Cash Management Services Ltd
NSE:RADIANTCMS
|
IN |
|
Aurskog Sparebank
OSE:AURG
|
NO |
|
O
|
Osaka Organic Chemical Industry Ltd
TSE:4187
|
JP |
|
Europa Metals Ltd
LSE:EUZ
|
AU |
|
Trans Lux Corp
OTC:TNLX
|
US |
|
Code Rebel Corp
OTC:CDRBQ
|
US |
|
HLS Therapeutics Inc
TSX:HLS
|
CA |
|
Sriwahana Adityakarta Tbk PT
IDX:SWAT
|
ID |
|
Empire Company Ltd
TSX:EMP.A
|
CA |
|
Vaxart Inc
NASDAQ:VXRT
|
US |
|
CeCors Inc
OTC:CEOS
|
CA |
|
A
|
American Films Inc
OTC:AMFL
|
US |
|
L
|
Lam Thao Fertilizers and Chemicals JSC
VN:LAS
|
VN |
|
M
|
Multicell Technologies Inc
OTC:MCET
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is INM's stock price target?
Not Available
INM doesn't have any price targets made by Wall Street professionals.
What is InMed Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-35%
-35%
The
compound annual growth rate
of InMed Pharmaceuticals Inc's revenue for the next 3 years is
-35%.
